Multiscale optical imaging for unraveling the in vivo fate of nanomedicine

Multiscale optical imaging for unraveling the in vivo fate of nanomedicine

Dr. Alexandros Marios Sofias, RWTH Aachen University, Germany

The Institute for Experimental Molecular Imaging’s (RWTH Aachen) research team uses MILabs Optical imaging system, intravital microscopy, and immunohistochemistry to investigate cancer nanomedicine delivery and uptake in vivo. The webinar focuses on how they use CT-guided fluorescent tomography (FLT/CT) and what they can get out of it.

Took place: EMIM, August 2021

CT,Optical

You may also like

Bart Cornelissen imaging DNA damage webinar thumbnail
Imaging DNA damage
CT,PET,SPECT
Each DNA damage repair pathway leads to the recruitment, upregulation, or activation of specific proteins within the nucleus, which, in some cases, can represent attractive targets for molecular imaging.
Fabian Kiessling webinar thumbnail
Quantitative hybrid fluorescence and CT to assess drug biodistribution in cancer research
CT,Optical
For a detailed biodistribution analysis, PET and SPECT are usually preferred as they are more accurate and quantitative, so the question is, can optical imaging become a complementary tool for pre-clinical biodistribution analysis.
webinar thumnail Marko Rosenholm
Dynamic SPECT/CT imaging of glymphatic drug delivery and clearance in small animals
CT,SPECT
Marko Rosenholm presents some of the findings and results regarding dynamic SPECT/CT imaging of a glymphatic system they have acquired with the MILabs VECTor/CT system.

Global Sales, Service & Support

Duwboot 7a
3991 CD  Houten
The Netherlands

Phone: +31 85 088 5753
Fax: +31 88 756 0094
E-mail: [email protected]
REQUEST MORE INFORMATION

Distributors

MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.

Please contact MILabs directly for more information about your local MILabs business partner.

Scroll to Top